Normal final height after treatment for acute lymphoblastic leukemia without irradiation

Publisher Website
Google Scholar
Abstract
In order to evaluate the influence of chemotherapy on linear growth, 28 children treated for acute lymphoblastic leukemia without irradiation were evaluated before, during and after the end of therapy. Median age at diagnosis was 4.4 years (range 2.2–12.7 years) and treatment was discontinued after a median period of 3.1 years (3.0–5.2 years). We observed a significant decrease in height SDS (p= 0.006) from diagnosis to the end of chemotherapy, followed by catch‐up in height SDS from the end of chemotherapy to final observation. Catch‐up growth took place mainly within the first 2 years after cessation of therapy. In 22 patients final height was reached. Final height was normal (median height SDS‐0.035) and even significantly higher than mid‐parental height SDS (p= 0.012). In those patients who attained adult stature, the sitting height to standing height ratio was also normal. In conclusion, in children treated for acute lymphoblastic leukemia, chemotherapy exerted a negative influence on growth, but catch‐up occurred within 2 years after cessation of therapy, resulting in normal final height and body proportions.